SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-16-002894
Filing Date
2016-05-31
Accepted
2016-05-31 06:06:48
Documents
9
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 ACASTI PHARMA INC. 20-F acasti20f.htm 20-F 2589830
2 EXHIBIT 12.1 exh12_1.htm EX-12.1 12887
3 EXHIBIT 12.2 exh12_2.htm EX-12.2 13406
4 EXHIBIT 13.1 exh13_1.htm EX-13.1 5547
5 EXHIBIT 13.2 exh13_2.htm EX-13.2 5847
6 kmpg-footer.jpg GRAPHIC 11933
7 kmpg-header.jpg GRAPHIC 12822
8 kmpg-logo.jpg GRAPHIC 4189
9 kmpg-sig.jpg GRAPHIC 4210
  Complete submission text file 0001102624-16-002894.txt   2674663
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 20-F | Act: 34 | File No.: 001-35776 | Film No.: 161683788
SIC: 2834 Pharmaceutical Preparations